Csilla Sipeky
csilla.sipeky@utu.fi +358 29 450 4541 +358 50 322 9101 Kiinamyllynkatu 10 Turku |
Publications
- A second update on mapping the human genetic architecture of COVID-19 (2023)
- Nature
(A1 Refereed original research article in a scientific journal) - Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants (2023)
- Nature Genetics
(A1 Refereed original research article in a scientific journal) - New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022)
- Nature Genetics
(A1 Refereed original research article in a scientific journal) - Overview of Registered Clinical Trials on Manual Therapy: Possible Implications of Genetic Testing for Personalized Treatment (2022)
- In Vivo
(A1 Refereed original research article in a scientific journal) - A humángenetikai eltérések lehetséges szerepe Covid-19-fertôzésben [A humángenetikai eltérések lehetséges szerepe Covid-19-fertôzésben] (2021)
- Lege Artis Medicinae
(A1 Refereed original research article in a scientific journal) - A Rare Variant in ERF (rs144812092) Predisposes to Prostate and Bladder Cancers in an Extended Pedigree (2021)
- Cancers
(A1 Refereed original research article in a scientific journal) - BioCPR–A Tool for Correlation Plots (2021)
- Data
(A1 Refereed original research article in a scientific journal) - Mapping the human genetic architecture of COVID-19 (2021)
- Nature
(A1 Refereed original research article in a scientific journal) - Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease (2021)
- Prostate Cancer and Prostatic Diseases
(A1 Refereed original research article in a scientific journal) - Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study (2021)
- European Urology Oncology
(A1 Refereed original research article in a scientific journal) - Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021)
- Nature Genetics
(A1 Refereed original research article in a scientific journal) - A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data (2020)
- Cancer Epidemiology, Biomarkers and Prevention
(A1 Refereed original research article in a scientific journal) - Genetic biomarkers to guide poly (ADP-ribose) polymerase inhibitor precision treatment of prostate cancer (2020)
- Pharmacogenomics
(A2 Refereed review article in a scientific journal ) - Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view (2020)
- Pharmacogenomics Journal
(A1 Refereed original research article in a scientific journal) - Prostate cancer risk prediction using a polygenic risk score (2020)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - ShAn: An easy-to-use tool for interactive and integrated variant annotation (2020)
- PLoS ONE
(A1 Refereed original research article in a scientific journal) - The effect of sample size on polygenic hazard models for prostate cancer (2020)
- European Journal of Human Genetics
(A1 Refereed original research article in a scientific journal) - The role of polygenic risk and susceptibility genes in breast cancer over the course of life (2020)
- Nature Communications
(A1 Refereed original research article in a scientific journal) - 4th ESPT Conference: Pharmacogenomics and personalized medicine - Research progress and clinical implementation (2019)
- Pharmacogenomics
(B1 Non-refereed article in a scientific journal) - 4th ESPT summer school: precision medicine and personalised health (2019)
- Pharmacogenomics
(Other publication)